Home › Funds › Vanderbilt University › BSX

Vanderbilt University position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Vanderbilt University reported holding 152,865 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$6.5M, representing 0.90% of its reported portfolio and ranking #19 among its reported holdings. Vanderbilt University has disclosed BSX holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)152.87K sh
Reported value held$6.52M
Portfolio Weight0.90%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vanderbilt University's BSX position evolved

Vanderbilt University first disclosed a stake in BSX in Q1 2024 at 43,443 shares (US$3.0M). The position peaked in Q2 2026 at 152,865 shares, worth US$6.5M. Across 9 filings, Vanderbilt University increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 152,865 shares valued at US$6.5M — an increase of 113,395 shares quarter over quarter.. Notable position changes include a 28% trim in Q4 2024 (shares rose 13% over the following quarter), a 90% increase in Q3 2025 (shares fell 2% over the following quarter), a 287% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 43.44K $2.98M New
Q2 2024 39.80K $3.06M Reduce
Q3 2024 32.90K $2.76M Reduce
Q4 2024 23.68K $2.12M Reduce
Q2 2025 13.78K $1.48M New
Q3 2025 26.16K $2.55M Add
Q4 2025 32.63K $3.11M Add
Q1 2026 39.47K $2.48M Add
Q2 2026 152.87K $6.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Vanderbilt University held BSX?

Vanderbilt University has disclosed BSX holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

What is Vanderbilt University's current position in BSX?

As of Q2 2026, Vanderbilt University holds 152.87K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $6.52M, representing 0.90% of its reported portfolio and ranking #19.

Has Vanderbilt University been buying or selling BSX?

In the latest 13F filing (Q2 2026), Vanderbilt University increased its position in BSX. The position peaked in Q2 2026 at 152.87K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.